HRGCNLDA:基于层次精细化图形卷积神经网络的lncRNA疾病关联的预测
Li Peng1,2, Yujie Yang1, Cheng Yang1
1College of Computer Science and Engineering, Hunan University of Science and Technology, Xiangtan 411201, China.
Mathematical biosciences and engineering : MBE
|June 14, 2024
概括
这项研究介绍了HRGCNLDA,这是一种用于预测长非编码RNA (lncRNA) -疾病关联的新计算方法. HRGCNLDA提高了识别潜在癌症生物标志物和治疗点的准确性.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 基因组学就是基因组学.
背景情况:
- 长非编码RNAs (lncRNAs) 是生物过程中的关键调节者,包括癌症免疫检查点.
- lncRNAs显示出作为癌症生物标志物和治疗点的前景.
- 对于 lncRNA-疾病关联发现的实验方法是耗时和劳动密集的.
研究的目的:
- 开发一种准确和高效的计算方法来预测 lncRNA 与疾病的关联.
- 为了解决这个任务的图形卷积神经网络中的过度平滑问题.
主要方法:
- 拟议的HRGCNLDA是一种层次精细化图形卷积神经网络方法.
- 在消息传播和节点更新期间增强层次表示.
- 专注于放大隐藏层贡献,同时最大限度地减少差异.
主要成果:
- 与现有方法相比,HRGCNLDA取得了更高的性能.
- 在实验中证明了最高的AUC-ROC和AUC-PR值.
- 通过对乳腺癌,肺癌和胃癌的病例研究验证了疗效.
结论:
- HRGCNLDA是一个可靠和有效的计算工具,用于 lncRNA-疾病关联预测.
- 该方法为实验技术提供了更有效的替代方案.
- 促进癌症生物标志物和治疗点发现的潜力.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K


